EHA HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSION: EPCORE CLL-1 TRIAL
OR
Chair
Dr. Robert Kridel
Panelists
Dr. Kerry Savage
Dr. Diego Villa
This program has been made possible through unrestricted support from Roche.
Studies/trials discussed:
- Outcomes of Autologous and Allogeneic Stem Cell Translantation for T-cell Lymphoma, An updated Analysis of the EBMT Lymphoma Working Party.
- EPCORE CLL-1 trial
